Dr. James H Ellis MD

Recommended Articles

• 32-year-old with Cystic Fibrosis Raises Millions for Research

  32-year old Emily Kramer-Golinkoff has accomplished more in her life than most people can say. Though she was diagnosed with a life-long debilitating disease as an infant, she has refused to let the fate she was dealt with drag her down. This young woman is the founder of a non-profit called Emily's...

• Gene Editing Has the Potential to Change Cystic Fibrosis

  Spiked Columnist, Tim Black, discusses advances in genetic editing in his article, Gene Editing: An Expression of Our Humanity.Tim Black questions how people should all consider the recent negative responses to some of the latest gene-editing successes. The majority of these gene-editing techniques...

• What Pathogens Can Cause Pneumonia?

  What are pathogens?Viruses, bacteria, fungus, or, in some rare cases, parasites and other microorganisms are involved in the development of pneumonia. Viruses cause the majority of pneumonia in young children. Adults who have weaker immunity are more frequently infected with bacteria.Pathogens, in...

• What Is Cytomegalovirus?

  What is cytomegalovirus?Cytomegalovirus (CMV) is a member of the herpes virus family. Others viruses that belong to the same family are:...

• What is Tuberculosis?

  Tuberculosis, or TB, is a bacterial infection that spreads by breathing droplets of sputum containing the infectious organism. It mainly affects the lungs but may also reach other parts of the body, like bones and nervous system, as the bacteria may spread through lymph nodes and the blood stream. A...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...